COVID-19 Disease. COVID-19 Disease
Conditions
Interventions
Intervention 1: Intervention group: In the intervention group, patients, in addition to the current standard treatments, also receive 600 cc survivor's plasma. For the preparation of fresh plasma prod
Sponsors
Mashhad University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 75 Years
Inclusion criteria
Inclusion criteria: Po2 / FIO2 ratio less than 300 despite receiving standard treatment The patient should be between 18 and 75 years old Normal IgA level Less than a week has passed since the patient entered the ICU
Exclusion criteria
Exclusion criteria: Uncontrolled HTN Advanced heart failure Systolic blood pressure less than 90 mm Hg COPD The patient is intubated Chronic renal failure with GFR less than 30 Advanced hepatic failure
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Mortality rate in 4 weeks from the time of entry into the study. Timepoint: The first month of entering the study. Method of measurement: Continuous clinical evaluation. | — |
Secondary
| Measure | Time frame |
|---|---|
| The length of hospital stay in the ICU from the time of entering the study. Timepoint: Daily evaluation. Method of measurement: Clinical evaluation. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr Mohsen Seddigh Shamsi
Mashhad University of Medical Sciences
Outcome results
None listed